📰 Wavewriter Alpha News
Wavewriter Alpha News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wavewriter Alpha. Real-time updates on events, politics, business and more.
January 22, 2024
Boston Scientific announced positive one-year results from a trial evaluating its spinal cord stimulation technology.
October 28, 2023
Boston Scientific Corporation (NYSE:BSX) Q3 2023 Earnings Call Transcript October 26, 2023 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.5, expectations were $0.48. Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be […]
October 28, 2023
Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
October 26, 2023
MARLBOROUGH, Mass., Oct. 26, 2023 /PRNewswire/ -- Boston Scientific Corporation generated net sales of $3.527 billion during the third quarter of 2023, growing 11.2 percent on a reported basis,...
October 23, 2023
With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.
October 11, 2023
MARLBOROUGH, Mass., Oct. 11, 2023 -- Boston Scientific Corporation today announced that the U.S. Food and Drug Administration has approved an expanded indication of the WaveWriter Alpha™...
October 11, 2023
The FDA has greenlit an expanded indication for the WaveWriter Alpha spinal cord stimulator systems from Boston Scientific.
April 19, 2023
The Chronic Pain Market is anticipated to grow from US$ 73.14 Billion in 2023 to US$ 142.53 Billion by 2033, rising at a CAGR of 6.9% during the forecast period. Globally, there were more than 187 Million cases of chronic pain in 2020, and from 2023 to 2033, it is predicted that this number would increase dramatical...
February 23, 2023
The chronic pain market is anticipated to grow from US$ 73.14 Bn in 2023 to US$ 142.53 Bn by 2033, rising at a CAGR of 6.9% during the forecast period. Globally, there were more than 187 Mn cases of chronic pain in 2020, and from 2023 to 2033, it is predicted that this number would increase dramatically.An ageing po...
February 2, 2023
Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2022 Earnings Call. All participants will be in listen only mode Please note, this event is being recorded.